The medical landscape for glucose is shifting, and transdermal GLP-1 delivery systems represent a potential breakthrough. Unlike subcutaneous injections, this method offers a more convenient way to administer GLP-1 medications. These devices steadily release the treatment through the epidermis offering a consistent amount of the beneficial agent… Read More